Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/ reperfusion injury in an in vivo rat heart model

Korean Journal of Anesthesiology

Volumn 61, Issue 6, 2011, Pages 499-505

  Shin, Il Woo ^a,c   Jang, In Seok ^b,c   Lee, Seung Min ^a   Park, Kyeong Eon ^a   Ok, Seong Ho ^a   Sohn, Ju Tae ^a,c   Lee, Heon Keun ^a,c   Chung, Young Kyun ^a,c  

^a Anesthesiology and Pain Medicine   (South Korea)

^b Departments of Cardiothoracic and Vascular Surgery   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Inflammation; Ischemia reperfusion; Myocardium; Ulinastatin

Indexed keywords

CREATINE KINASE; MYELOPEROXIDASE; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN; ULISTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; IN VIVO STUDY; LEFT CORONARY ARTERY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 84855338108     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2011.61.6.499     Document Type: Article

References (23)

1. Davis AE 3rd, Mejia P, Lu F. Biological activities of C1 inhibitor. Mol Immunol 2008; 45: 4057-63.
2. Owen CA, Campbell EJ. The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol 1999; 65: 137-50.
3. Shibata T, Yamamoto F, Suehiro S, Kinoshita H. Effects of protease inhibitors on postischemic recovery of the heart. Cardiovasc Drugs Ther 1997; 11: 547-56.
4. Harada N, Okajima K, Kushimoto S. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. Crit Care Med 1999; 27: 1958-64.
5. Pugia MJ, Lott JA. Pathophysiology and diagnostic value of urinary trypsin inhibitors. Clin Chem Lab Med 2005; 43: 1-16.
6. Masuda T, Sato K, Noda C, Ikeda KM, Matsunaga A, Ogura MN, et al. Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med 2003; 31: 1987-92.
7. Cao ZL, Okazaki Y, Naito K, Ueno T, Natsuaki M, Itoh T. Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart. Ann Thorac Surg 2000; 69: 1121-6.
8. Yano T, Anraku S, Nakayama R, Ushijima K. Neuroprotective effect of urinary trysin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology 2003; 98: 465-73.
9. Koga Y, Fujita M, Tsuruta R, Koda Y, Nakahara T, Yagi T, et al. Urinary trypsin inhibitor suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats. Neurol Res 2010; 32: 925-32.
10. Wu YJ, Ling Q, Zhou XH, Wang Y, Xie HY, Yu JR, et al. Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation. Hepatobiliary Pancreat Dis Int 2009; 8: 53-8.
11. Aihara T, Shiraishi M, Hiroyasu S, Hatsuse K, Mochizuki H, Seki S, et al. Ulinastatin, a protease inhibitor, attenuates hepatic ischemia/ reperfusion injury by downregulating TNF-alpha in the liver. Transplant Proc 1998; 30: 3732-4.
12. Chen CC, Liu ZM, Wang HH, He W, Wang Y, Wu WD. Effects of ulinastatin on renal ischemia-reperfusion injury in rats. Acta Phamacol Sin 2004; 25: 1334-40.
13. Ren B, Wu H, Zhu J, Li D, Shen Y, Ying R, et al. Ulinastatin attenuates lung ischemia-reperfusion injury in rats by inhibiting tumor necrosis factor alpha. Transplant Proc 2006; 38: 2777-9.
14. Shin IW, Jang IS, Lee SH, Baik JS, Park KE, Sohn JT, et al. Propofol has delayed myocardial protective effects after a regional ischemia/ reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol 2010; 58: 378-82.
15. Jang IS, Park MY, Shin IW, Sohn JT, Lee HK, Chung YK. Ethyl pyruvate has anti-inflammatory and delayed myocardial protective effects after regional ischemia/reperfusion injury. Yonsei Med J 2010; 51: 838-44.
16. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-84.
17. Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW. Myocardial infarction after noncardiac surgery. Anesthesiology 1998; 88: 572-8.
18. Mark DB, Nelson CL, Califf RM, Harrell FE Jr, Lee KL, Jones RH, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 1994; 89: 2015-25.
19. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995; 91: 1872-85.
20. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31-47.
21. Goldmann BU, Rudolph V, Rudolph TK, Holle AK, Hillebrandt M, Meinertz T, et al. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction. Free Radic Biol Med 2009; 47: 79-83.
22. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995; 146: 419-28.
23. Zhao ZQ, Velez DA, Wang NP, Hewan-Lowe KO, Nakamura M, Guyton RA, et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 2001; 6: 279-90.